Ignite Creation Date:
2024-05-06 @ 1:31 AM
Last Modification Date:
2024-10-26 @ 11:05 AM
Study NCT ID:
NCT01822314
Status:
COMPLETED
Last Update Posted:
2024-03-07
First Post:
2013-03-25
Brief Title:
Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer
Sponsor:
Organization:
Fondazione Michelangelo